Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
23001
23002
23003
23004
23005
23006
23007
23008
23009
23010
23011
23012
23013
23014
23015
23016
23017
23018
23019
23020
23021
23022
23023
23024
23025
23026
23027
23028
23029
23030
23031
23032
23033
23034
23035
23036
23037
23038
23039
23040
23041
23042
23043
23044
23045
23046
23047
23048
23049
23050
23051
23052
23053
23054
23055
23056
23057
23058
23059
23060
23061
23062
23063
23064
23065
23066
23067
23068
23069
23070
23071
23072
23073
23074
23075
23076
23077
23078
23079
23080
23081
23082
23083
23084
23085
23086
23087
23088
23089
23090
23091
23092
23093
23094
23095
23096
23097
23098
23099
23100
23101
23102
23103
23104
23105
23106
23107
23108
23109
23110
23111
23112
23113
23114
23115
23116
23117
23118
23119
23120
23121
23122
23123
23124
23125
23126
23127
23128
23129
23130
23131
23132
23133
23134
23135
23136
23137
23138
23139
23140
23141
23142
23143
23144
23145
23146
23147
23148
23149
23150
23151
23152
23153
23154
23155
23156
23157
23158
23159
23160
23161
23162
23163
23164
23165
23166
23167
23168
23169
23170
23171
23172
23173
23174
23175
23176
23177
23178
23179
23180
23181
23182
23183
23184
23185
23186
23187
23188
23189
23190
23191
23192
23193
23194
23195
23196
23197
23198
23199
23200
| UnnamedSample_HQ_transcript/96380|m.22153 | UnnamedSample_HQ_transcript/96380 | Identity 0.941 too low. | 79154fe36f79dc7230b9b9eb4762e727 | 314 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 2 | 291 | 1.5E-41 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/91679|m.21496 | UnnamedSample_HQ_transcript/91679 | Identity 0.770 too low. | 79154fe36f79dc7230b9b9eb4762e727 | 314 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 2 | 291 | 1.5E-41 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/99570|m.22572 | UnnamedSample_HQ_transcript/99570 | Identity 0.717 too low. | 79154fe36f79dc7230b9b9eb4762e727 | 314 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 2 | 291 | 1.5E-41 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/35130|m.10738 | UnnamedSample_HQ_transcript/35130 | Coverage 0.921 too low. | c7933368b9ab9a19e6310974fa5db5ca | 408 | Pfam | PF00096 | Zinc finger, C2H2 type | 7 | 29 | 1.6E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/35130|m.10738 | UnnamedSample_HQ_transcript/35130 | Coverage 0.921 too low. | c7933368b9ab9a19e6310974fa5db5ca | 408 | Pfam | PF00096 | Zinc finger, C2H2 type | 35 | 57 | 5.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/35130|m.10738 | UnnamedSample_HQ_transcript/35130 | Coverage 0.921 too low. | c7933368b9ab9a19e6310974fa5db5ca | 408 | Pfam | PF00096 | Zinc finger, C2H2 type | 124 | 146 | 8.6E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/98921|m.22483 | UnnamedSample_HQ_transcript/98921 | Coverage 0.969 too low. | 33edb9083d2e6a406a109380dec9671e | 357 | Pfam | PF00047 | Immunoglobulin domain | 2 | 109 | 1.6E-6 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/7008|m.2864 | UnnamedSample_HQ_transcript/7008 | Coverage 0.942 too low. | 86601b00abc5212a03105d800847d765 | 1311 | Pfam | PF08687 | Apx/Shroom domain ASD2 | 1014 | 1297 | 3.2E-58 | T | 22-09-2020 | IPR014799 | Apx/Shrm Domain 2 |
| UnnamedSample_HQ_transcript/4848|m.2134 | UnnamedSample_HQ_transcript/4848 | Coverage 0.872 too low. | 86601b00abc5212a03105d800847d765 | 1311 | Pfam | PF08687 | Apx/Shroom domain ASD2 | 1014 | 1297 | 3.2E-58 | T | 22-09-2020 | IPR014799 | Apx/Shrm Domain 2 |
| UnnamedSample_HQ_transcript/36514|m.11051 | UnnamedSample_HQ_transcript/36514 | Coverage 0.959 too low. | afdcd0de60a037e7d567184ac6207695 | 553 | Pfam | PF00728 | Glycosyl hydrolase family 20, catalytic domain | 131 | 276 | 2.2E-14 | T | 22-09-2020 | IPR015883 | Glycoside hydrolase family 20, catalytic domain |
| UnnamedSample_HQ_transcript/67751|m.17534 | UnnamedSample_HQ_transcript/67751 | Coverage 0.935 too low. | f85ab1d08cde1aac24008acb8e8a74b5 | 543 | Pfam | PF00567 | Tudor domain | 384 | 502 | 1.1E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/96498|m.22163 | UnnamedSample_HQ_transcript/96498 | Coverage 0.287 too low. | cd87b5dcefcf456ecbf0da6bffaf205e | 319 | Pfam | PF00732 | GMC oxidoreductase | 100 | 315 | 2.4E-46 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/38696|m.11552 | UnnamedSample_HQ_transcript/38696 | Coverage 0.888 too low. | 079fa5d3ef908df1c3bd5ee995fe755b | 186 | Pfam | PF00026 | Eukaryotic aspartyl protease | 3 | 173 | 6.4E-26 | T | 22-09-2020 | IPR033121 | Peptidase family A1 domain |
| UnnamedSample_HQ_transcript/2482|m.1225 | UnnamedSample_HQ_transcript/2482 | Coverage 0.211 too low. | ca708a8b72418fea9f6177a3296ef838 | 1142 | Pfam | PF00069 | Protein kinase domain | 743 | 1048 | 1.3E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/2482|m.1225 | UnnamedSample_HQ_transcript/2482 | Coverage 0.211 too low. | ca708a8b72418fea9f6177a3296ef838 | 1142 | Pfam | PF00627 | UBA/TS-N domain | 91 | 124 | 3.5E-6 | T | 22-09-2020 | IPR015940 | Ubiquitin-associated domain |
| UnnamedSample_HQ_transcript/64081|m.16858 | UnnamedSample_HQ_transcript/64081 | Coverage 0.128 too low. | 9d3595f2ca4c73bfdb9fde06653f42ba | 457 | Pfam | PF02535 | ZIP Zinc transporter | 53 | 435 | 1.4E-55 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/63986|m.16836 | UnnamedSample_HQ_transcript/63986 | Coverage 0.114 too low. | 9d3595f2ca4c73bfdb9fde06653f42ba | 457 | Pfam | PF02535 | ZIP Zinc transporter | 53 | 435 | 1.4E-55 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/58019|m.15653 | UnnamedSample_HQ_transcript/58019 | Coverage 0.144 too low. | 9d3595f2ca4c73bfdb9fde06653f42ba | 457 | Pfam | PF02535 | ZIP Zinc transporter | 53 | 435 | 1.4E-55 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/70795|m.18068 | UnnamedSample_HQ_transcript/70795 | Coverage 0.124 too low. | 9d3595f2ca4c73bfdb9fde06653f42ba | 457 | Pfam | PF02535 | ZIP Zinc transporter | 53 | 435 | 1.4E-55 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/4497|m.1999 | UnnamedSample_HQ_transcript/4497 | Coverage 0.930 too low. | 25140ac2936771a06e94343bc04aa870 | 1027 | Pfam | PF00433 | Protein kinase C terminal domain | 980 | 1022 | 1.7E-10 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/4497|m.1999 | UnnamedSample_HQ_transcript/4497 | Coverage 0.930 too low. | 25140ac2936771a06e94343bc04aa870 | 1027 | Pfam | PF02185 | Hr1 repeat | 257 | 319 | 5.3E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/4497|m.1999 | UnnamedSample_HQ_transcript/4497 | Coverage 0.930 too low. | 25140ac2936771a06e94343bc04aa870 | 1027 | Pfam | PF02185 | Hr1 repeat | 162 | 226 | 4.8E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/4497|m.1999 | UnnamedSample_HQ_transcript/4497 | Coverage 0.930 too low. | 25140ac2936771a06e94343bc04aa870 | 1027 | Pfam | PF02185 | Hr1 repeat | 44 | 100 | 2.3E-8 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/4497|m.1999 | UnnamedSample_HQ_transcript/4497 | Coverage 0.930 too low. | 25140ac2936771a06e94343bc04aa870 | 1027 | Pfam | PF00069 | Protein kinase domain | 700 | 958 | 5.4E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/76451|m.19105 | UnnamedSample_HQ_transcript/76451 | Coverage 0.939 too low. | 37933c4d5901462a33886ef06ee497c5 | 287 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 5 | 194 | 4.9E-14 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/76451|m.19105 | UnnamedSample_HQ_transcript/76451 | Coverage 0.939 too low. | 37933c4d5901462a33886ef06ee497c5 | 287 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 194 | 260 | 4.3E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/38064|m.11410 | UnnamedSample_HQ_transcript/38064 | Coverage 0.062 too low. | 62dc51b087ff1b4ddca0e791692e0449 | 351 | Pfam | PF01087 | Galactose-1-phosphate uridyl transferase, N-terminal domain | 6 | 178 | 1.1E-61 | T | 22-09-2020 | IPR005849 | Galactose-1-phosphate uridyl transferase, N-terminal |
| UnnamedSample_HQ_transcript/38064|m.11410 | UnnamedSample_HQ_transcript/38064 | Coverage 0.062 too low. | 62dc51b087ff1b4ddca0e791692e0449 | 351 | Pfam | PF02744 | Galactose-1-phosphate uridyl transferase, C-terminal domain | 186 | 350 | 8.5E-54 | T | 22-09-2020 | IPR005850 | Galactose-1-phosphate uridyl transferase, C-terminal |
| UnnamedSample_HQ_transcript/53635|m.14771 | UnnamedSample_HQ_transcript/53635 | Coverage 0.041 too low. | 1f5a8f5db43ec2e6b80001d8125c67d3 | 212 | Pfam | PF01105 | emp24/gp25L/p24 family/GOLD | 24 | 199 | 8.6E-39 | T | 22-09-2020 | IPR009038 | GOLD domain |
| UnnamedSample_HQ_transcript/14152|m.5153 | UnnamedSample_HQ_transcript/14152 | Coverage 0.722 too low. | edfa0cdcf6a8c9958b89291f1abc3e46 | 1069 | Pfam | PF00612 | IQ calmodulin-binding motif | 927 | 944 | 0.034 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/14152|m.5153 | UnnamedSample_HQ_transcript/14152 | Coverage 0.722 too low. | edfa0cdcf6a8c9958b89291f1abc3e46 | 1069 | Pfam | PF00612 | IQ calmodulin-binding motif | 979 | 996 | 0.013 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/14152|m.5153 | UnnamedSample_HQ_transcript/14152 | Coverage 0.722 too low. | edfa0cdcf6a8c9958b89291f1abc3e46 | 1069 | Pfam | PF00612 | IQ calmodulin-binding motif | 954 | 973 | 0.18 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/14152|m.5153 | UnnamedSample_HQ_transcript/14152 | Coverage 0.722 too low. | edfa0cdcf6a8c9958b89291f1abc3e46 | 1069 | Pfam | PF00063 | Myosin head (motor domain) | 141 | 888 | 2.2E-221 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/14152|m.5153 | UnnamedSample_HQ_transcript/14152 | Coverage 0.722 too low. | edfa0cdcf6a8c9958b89291f1abc3e46 | 1069 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 10 | 106 | 6.5E-11 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/31078|m.9730 | UnnamedSample_HQ_transcript/31078 | Coverage 0.932 too low. | cb80ef4224e938992f9b136ca91e0a98 | 308 | Pfam | PF01694 | Rhomboid family | 107 | 267 | 3.5E-42 | T | 22-09-2020 | IPR022764 | Peptidase S54, rhomboid domain |
| UnnamedSample_HQ_transcript/94682|m.21903 | UnnamedSample_HQ_transcript/94682 | Coverage 0.989 too low. | e404556081cd49f56551d5931a760910 | 281 | Pfam | PF13489 | Methyltransferase domain | 80 | 200 | 1.1E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/31617|m.9857 | UnnamedSample_HQ_transcript/31617 | Coverage 0.470 too low. | d7c02da35b2b3b959acd720a488a6ca6 | 457 | Pfam | PF00412 | LIM domain | 369 | 424 | 1.8E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/52723|m.14587 | UnnamedSample_HQ_transcript/52723 | Coverage 0.864 too low. | 6b328f781fde586ce29c8f25c25f03f5 | 601 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 23 | 75 | 2.0E-4 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/52723|m.14587 | UnnamedSample_HQ_transcript/52723 | Coverage 0.864 too low. | 6b328f781fde586ce29c8f25c25f03f5 | 601 | Pfam | PF14598 | PAS domain | 307 | 416 | 3.3E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/61885|m.16425 | UnnamedSample_HQ_transcript/61885 | Coverage 0.951 too low. | 6b328f781fde586ce29c8f25c25f03f5 | 601 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 23 | 75 | 2.0E-4 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/61885|m.16425 | UnnamedSample_HQ_transcript/61885 | Coverage 0.951 too low. | 6b328f781fde586ce29c8f25c25f03f5 | 601 | Pfam | PF14598 | PAS domain | 307 | 416 | 3.3E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/10004|m.3831 | UnnamedSample_HQ_transcript/10004 | Coverage 0.980 too low. | 92fa0a28556192a419ba38e875e96842 | 1223 | Pfam | PF00435 | Spectrin repeat | 392 | 490 | 7.7E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/23698|m.7861 | UnnamedSample_HQ_transcript/23698 | Coverage 0.885 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 353 | 399 | 5.2E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/23698|m.7861 | UnnamedSample_HQ_transcript/23698 | Coverage 0.885 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 426 | 473 | 8.8E-10 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/23698|m.7861 | UnnamedSample_HQ_transcript/23698 | Coverage 0.885 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 280 | 326 | 1.1E-5 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/21644|m.7324 | UnnamedSample_HQ_transcript/21644 | Coverage 0.851 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 353 | 399 | 5.2E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/21644|m.7324 | UnnamedSample_HQ_transcript/21644 | Coverage 0.851 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 426 | 473 | 8.8E-10 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/21644|m.7324 | UnnamedSample_HQ_transcript/21644 | Coverage 0.851 too low. | 4283d7d1e5b2d8c09a9d7f8c402189a5 | 537 | Pfam | PF00571 | CBS domain | 280 | 326 | 1.1E-5 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/60817|m.16222 | UnnamedSample_HQ_transcript/60817 | Coverage 0.407 too low. | c0d5da7719cbc39a0ea7cf8d91c56d77 | 244 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 14 | 218 | 3.6E-45 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/12056|m.4511 | UnnamedSample_HQ_transcript/12056 | Coverage 0.728 too low. | cfe5b6ca4b6fef267275cc4e55ecdb77 | 706 | Pfam | PF15913 | Furin-like repeat, cysteine-rich | 439 | 501 | 1.4E-6 | T | 22-09-2020 | IPR043601 | R-spondin, Fu-CRD domain |
| UnnamedSample_HQ_transcript/12056|m.4511 | UnnamedSample_HQ_transcript/12056 | Coverage 0.728 too low. | cfe5b6ca4b6fef267275cc4e55ecdb77 | 706 | Pfam | PF14843 | Growth factor receptor domain IV | 124 | 232 | 1.3E-14 | T | 22-09-2020 | IPR032778 | Growth factor receptor domain 4 |
| UnnamedSample_HQ_transcript/59798|m.16017 | UnnamedSample_HQ_transcript/59798 | Coverage 0.299 too low. | a70614613d955462295f5ce3b5bb2c52 | 604 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 506 | 588 | 8.8E-19 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/59798|m.16017 | UnnamedSample_HQ_transcript/59798 | Coverage 0.299 too low. | a70614613d955462295f5ce3b5bb2c52 | 604 | Pfam | PF08412 | Ion transport protein N-terminal | 108 | 151 | 1.5E-24 | T | 22-09-2020 | IPR013621 | Ion transport N-terminal |
| UnnamedSample_HQ_transcript/59798|m.16017 | UnnamedSample_HQ_transcript/59798 | Coverage 0.299 too low. | a70614613d955462295f5ce3b5bb2c52 | 604 | Pfam | PF00520 | Ion transport protein | 153 | 414 | 1.4E-20 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/17058|m.6024 | UnnamedSample_HQ_transcript/17058 | Coverage 0.855 too low. | b602b4e026767666439d2100ca28a79b | 538 | Pfam | PF13907 | Domain of unknown function (DUF4208) | 420 | 509 | 6.7E-24 | T | 22-09-2020 | IPR025260 | Domain of unknown function DUF4208 |
| UnnamedSample_HQ_transcript/17058|m.6024 | UnnamedSample_HQ_transcript/17058 | Coverage 0.855 too low. | b602b4e026767666439d2100ca28a79b | 538 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 113 | 206 | 1.5E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/10748|m.4064 | UnnamedSample_HQ_transcript/10748 | Unmapped. | 1a8cbfcb587472441c3411480603341e | 873 | Pfam | PF00910 | RNA helicase | 494 | 602 | 2.6E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/10741|m.4060 | UnnamedSample_HQ_transcript/10741 | Coverage 0.986 too low. | 86cceb5d7a8a8a4a26e1b1323c41b392 | 1115 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 842 | 1101 | 5.0E-84 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/10741|m.4060 | UnnamedSample_HQ_transcript/10741 | Coverage 0.986 too low. | 86cceb5d7a8a8a4a26e1b1323c41b392 | 1115 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 465 | 707 | 3.6E-46 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/10741|m.4060 | UnnamedSample_HQ_transcript/10741 | Coverage 0.986 too low. | 86cceb5d7a8a8a4a26e1b1323c41b392 | 1115 | Pfam | PF00017 | SH2 domain | 320 | 399 | 7.3E-6 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/63634|m.16763 | UnnamedSample_HQ_transcript/63634 | Identity 0.120 too low. | 0ad788c15c40270ad37b004d91ba8295 | 526 | Pfam | PF02463 | RecF/RecN/SMC N terminal domain | 299 | 504 | 3.2E-12 | T | 22-09-2020 | IPR003395 | RecF/RecN/SMC, N-terminal |
| UnnamedSample_HQ_transcript/77537|m.19297 | UnnamedSample_HQ_transcript/77537 | Coverage 0.187 too low. | 311d99daa422e6c3b65467b1550e5913 | 421 | Pfam | PF00096 | Zinc finger, C2H2 type | 363 | 384 | 0.002 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/77537|m.19297 | UnnamedSample_HQ_transcript/77537 | Coverage 0.187 too low. | 311d99daa422e6c3b65467b1550e5913 | 421 | Pfam | PF00096 | Zinc finger, C2H2 type | 393 | 416 | 0.0024 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/77537|m.19297 | UnnamedSample_HQ_transcript/77537 | Coverage 0.187 too low. | 311d99daa422e6c3b65467b1550e5913 | 421 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/117280|m.24619 | UnnamedSample_HQ_transcript/117280 | Coverage 0.939 too low. | d2e92ba9aec7665f95e0088b2990bcab | 128 | Pfam | PF01423 | LSM domain | 9 | 72 | 6.8E-13 | T | 22-09-2020 | IPR001163 | LSM domain, eukaryotic/archaea-type |
| UnnamedSample_HQ_transcript/120663|m.24894 | UnnamedSample_HQ_transcript/120663 | Coverage 0.889 too low. | d2e92ba9aec7665f95e0088b2990bcab | 128 | Pfam | PF01423 | LSM domain | 9 | 72 | 6.8E-13 | T | 22-09-2020 | IPR001163 | LSM domain, eukaryotic/archaea-type |
| UnnamedSample_HQ_transcript/119450|m.24809 | UnnamedSample_HQ_transcript/119450 | Coverage 0.891 too low. | d2e92ba9aec7665f95e0088b2990bcab | 128 | Pfam | PF01423 | LSM domain | 9 | 72 | 6.8E-13 | T | 22-09-2020 | IPR001163 | LSM domain, eukaryotic/archaea-type |
| UnnamedSample_HQ_transcript/9976|m.3820 | UnnamedSample_HQ_transcript/9976 | Coverage 0.199 too low. | 626f9ab82a7ff0add68421939628c7e8 | 875 | Pfam | PF00567 | Tudor domain | 673 | 793 | 1.9E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/9976|m.3820 | UnnamedSample_HQ_transcript/9976 | Coverage 0.199 too low. | 626f9ab82a7ff0add68421939628c7e8 | 875 | Pfam | PF00013 | KH domain | 575 | 636 | 1.5E-10 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/4179|m.1874 | UnnamedSample_HQ_transcript/4179 | Unmapped. | 0e4811e193df4901af8ba586d86da371 | 867 | Pfam | PF08447 | PAS fold | 254 | 340 | 1.4E-20 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/4179|m.1874 | UnnamedSample_HQ_transcript/4179 | Unmapped. | 0e4811e193df4901af8ba586d86da371 | 867 | Pfam | PF13426 | PAS domain | 97 | 152 | 0.025 | T | 22-09-2020 | IPR000014 | PAS domain |
| UnnamedSample_HQ_transcript/4179|m.1874 | UnnamedSample_HQ_transcript/4179 | Unmapped. | 0e4811e193df4901af8ba586d86da371 | 867 | Pfam | PF08778 | HIF-1 alpha C terminal transactivation domain | 831 | 866 | 7.3E-19 | T | 22-09-2020 | IPR014887 | HIF-1 alpha, transactivation domain, C-terminal |
| UnnamedSample_HQ_transcript/4179|m.1874 | UnnamedSample_HQ_transcript/4179 | Unmapped. | 0e4811e193df4901af8ba586d86da371 | 867 | Pfam | PF11413 | Hypoxia-inducible factor-1 | 512 | 544 | 1.9E-17 | T | 22-09-2020 | IPR021537 | Hypoxia-inducible factor, alpha subunit |
| UnnamedSample_HQ_transcript/99234|m.22526 | UnnamedSample_HQ_transcript/99234 | Coverage 0.983 too low. | c6c86092091103ace7c11bc86a97e678 | 339 | Pfam | PF00270 | DEAD/DEAH box helicase | 84 | 253 | 5.0E-48 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/73923|m.18631 | UnnamedSample_HQ_transcript/73923 | Coverage 0.221 too low. | 30a1c04d7f1712bc8dd5502d931546b5 | 445 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/73923|m.18631 | UnnamedSample_HQ_transcript/73923 | Coverage 0.221 too low. | 30a1c04d7f1712bc8dd5502d931546b5 | 445 | Pfam | PF00096 | Zinc finger, C2H2 type | 416 | 439 | 0.0043 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/73923|m.18631 | UnnamedSample_HQ_transcript/73923 | Coverage 0.221 too low. | 30a1c04d7f1712bc8dd5502d931546b5 | 445 | Pfam | PF00096 | Zinc finger, C2H2 type | 387 | 408 | 0.013 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/94689|m.21905 | UnnamedSample_HQ_transcript/94689 | Coverage 0.900 too low. | a06cc399ddf8369234c5465682a1dea1 | 164 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 7 | 150 | 2.4E-16 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF13927 | Immunoglobulin domain | 451 | 527 | 5.0E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF07679 | Immunoglobulin I-set domain | 35 | 114 | 2.5E-8 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 362 | 430 | 1.6E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 150 | 234 | 1.3E-10 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 563 | 632 | 4.6E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/40665|m.11999 | UnnamedSample_HQ_transcript/40665 | Coverage 0.982 too low. | d47eb9285c8bf3c37ea6e35f4fb5b6f7 | 649 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 270 | 330 | 1.5E-6 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/94465|m.21869 | UnnamedSample_HQ_transcript/94465 | Coverage 0.641 too low. | 8b2124cc9d72ecc6a55c559498286622 | 189 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 41 | 172 | 8.2E-32 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/99773|m.22602 | UnnamedSample_HQ_transcript/99773 | Coverage 0.602 too low. | 8b2124cc9d72ecc6a55c559498286622 | 189 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 41 | 172 | 8.2E-32 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/26515|m.8609 | UnnamedSample_HQ_transcript/26515 | Coverage 0.318 too low. | 8b2124cc9d72ecc6a55c559498286622 | 189 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 41 | 172 | 8.2E-32 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/90146|m.21276 | UnnamedSample_HQ_transcript/90146 | Coverage 0.580 too low. | 8b2124cc9d72ecc6a55c559498286622 | 189 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 41 | 172 | 8.2E-32 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/88621|m.21035 | UnnamedSample_HQ_transcript/88621 | Coverage 0.965 too low. | b10b4166f17272a6cc40e21ddf9a51a0 | 204 | Pfam | PF02188 | GoLoco motif | 99 | 120 | 5.2E-9 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/88621|m.21035 | UnnamedSample_HQ_transcript/88621 | Coverage 0.965 too low. | b10b4166f17272a6cc40e21ddf9a51a0 | 204 | Pfam | PF02188 | GoLoco motif | 181 | 200 | 2.6E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/88621|m.21035 | UnnamedSample_HQ_transcript/88621 | Coverage 0.965 too low. | b10b4166f17272a6cc40e21ddf9a51a0 | 204 | Pfam | PF02188 | GoLoco motif | 50 | 71 | 6.1E-12 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/6157|m.2594 | UnnamedSample_HQ_transcript/6157 | Coverage 0.891 too low. | 0036dcb1778aae0b866a112094824cf8 | 1471 | Pfam | PF01576 | Myosin tail | 847 | 1461 | 1.3E-94 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/6157|m.2594 | UnnamedSample_HQ_transcript/6157 | Coverage 0.891 too low. | 0036dcb1778aae0b866a112094824cf8 | 1471 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 3.7E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/6157|m.2594 | UnnamedSample_HQ_transcript/6157 | Coverage 0.891 too low. | 0036dcb1778aae0b866a112094824cf8 | 1471 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 767 | 4.0E-283 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/9175|m.3566 | UnnamedSample_HQ_transcript/9175 | Coverage 0.904 too low. | 66a7ea827ab0240e02429711d432f9b6 | 1154 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 961 | 1124 | 1.4E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/68031|m.17580 | UnnamedSample_HQ_transcript/68031 | Coverage 0.723 too low. | 4ad5e1363ed02aa03bb4b1301c66c8db | 427 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/71624|m.18232 | UnnamedSample_HQ_transcript/71624 | Coverage 0.754 too low. | 4ad5e1363ed02aa03bb4b1301c66c8db | 427 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/92232|m.21570 | UnnamedSample_HQ_transcript/92232 | Coverage 0.160 too low. | 6784ecf41f8d94f8f7a1413bdf949d8e | 209 | Pfam | PF01151 | GNS1/SUR4 family | 1 | 111 | 2.1E-26 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/60396|m.16141 | UnnamedSample_HQ_transcript/60396 | Coverage 0.978 too low. | 8cb78e333f76f6e7bb382f5c2c2e8d68 | 461 | Pfam | PF13855 | Leucine rich repeat | 130 | 189 | 7.0E-18 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/60396|m.16141 | UnnamedSample_HQ_transcript/60396 | Coverage 0.978 too low. | 8cb78e333f76f6e7bb382f5c2c2e8d68 | 461 | Pfam | PF13855 | Leucine rich repeat | 251 | 307 | 4.5E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/60396|m.16141 | UnnamedSample_HQ_transcript/60396 | Coverage 0.978 too low. | 8cb78e333f76f6e7bb382f5c2c2e8d68 | 461 | Pfam | PF13855 | Leucine rich repeat | 59 | 102 | 9.6E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/76501|m.19121 | UnnamedSample_HQ_transcript/76501 | Coverage 0.751 too low. | ca033747cf610fa63e51920d7707d699 | 380 | Pfam | PF00412 | LIM domain | 185 | 240 | 9.8E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/8022|m.3192 | UnnamedSample_HQ_transcript/8022 | Coverage 0.160 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 792 | 913 | 4.5E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/8022|m.3192 | UnnamedSample_HQ_transcript/8022 | Coverage 0.160 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 3.9E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/8022|m.3192 | UnnamedSample_HQ_transcript/8022 | Coverage 0.160 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 187 | 752 | 7.5E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/7792|m.3120 | UnnamedSample_HQ_transcript/7792 | Coverage 0.158 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 792 | 913 | 4.5E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/7792|m.3120 | UnnamedSample_HQ_transcript/7792 | Coverage 0.158 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 3.9E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/7792|m.3120 | UnnamedSample_HQ_transcript/7792 | Coverage 0.158 too low. | 4a926110c30c96f74a4415081f0578bd | 1180 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 187 | 752 | 7.5E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/24345|m.8033 | UnnamedSample_HQ_transcript/24345 | Coverage 0.971 too low. | 44b242a01e2b70f9b62198cb1904e120 | 808 | Pfam | PF05679 | Chondroitin N-acetylgalactosaminyltransferase | 245 | 791 | 2.2E-179 | T | 22-09-2020 | IPR008428 | Chondroitin N-acetylgalactosaminyltransferase |
| UnnamedSample_HQ_transcript/54487|m.14939 | UnnamedSample_HQ_transcript/54487 | Unmapped. | 6d8a0a340c8d8d504a04e2523584a791 | 268 | Pfam | PF00889 | Elongation factor TS | 73 | 265 | 6.2E-59 | T | 22-09-2020 | IPR014039 | Translation elongation factor EFTs/EF1B, dimerisation |
| UnnamedSample_HQ_transcript/75508|m.18939 | UnnamedSample_HQ_transcript/75508 | Identity 0.900 too low. | b6b1a375ff6c9383aaaed4a8ef5aa39e | 484 | Pfam | PF00096 | Zinc finger, C2H2 type | 377 | 399 | 6.0E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/75508|m.18939 | UnnamedSample_HQ_transcript/75508 | Identity 0.900 too low. | b6b1a375ff6c9383aaaed4a8ef5aa39e | 484 | Pfam | PF00096 | Zinc finger, C2H2 type | 405 | 427 | 0.0025 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/75508|m.18939 | UnnamedSample_HQ_transcript/75508 | Identity 0.900 too low. | b6b1a375ff6c9383aaaed4a8ef5aa39e | 484 | Pfam | PF00096 | Zinc finger, C2H2 type | 284 | 306 | 0.001 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/75508|m.18939 | UnnamedSample_HQ_transcript/75508 | Identity 0.900 too low. | b6b1a375ff6c9383aaaed4a8ef5aa39e | 484 | Pfam | PF00096 | Zinc finger, C2H2 type | 312 | 334 | 5.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/76278|m.19075 | UnnamedSample_HQ_transcript/76278 | Coverage 0.179 too low. | 63f9511208a220237da03654dbb0ce29 | 418 | Pfam | PF00096 | Zinc finger, C2H2 type | 391 | 414 | 2.1E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/76278|m.19075 | UnnamedSample_HQ_transcript/76278 | Coverage 0.179 too low. | 63f9511208a220237da03654dbb0ce29 | 418 | Pfam | PF00096 | Zinc finger, C2H2 type | 361 | 381 | 0.0087 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/76278|m.19075 | UnnamedSample_HQ_transcript/76278 | Coverage 0.179 too low. | 63f9511208a220237da03654dbb0ce29 | 418 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.3E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/71314|m.18173 | UnnamedSample_HQ_transcript/71314 | Coverage 0.495 too low. | 32f8dc5adbd28695042c5a942542740b | 523 | Pfam | PF00012 | Hsp70 protein | 5 | 523 | 2.3E-214 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/17534|m.6168 | UnnamedSample_HQ_transcript/17534 | Coverage 0.928 too low. | c71007747c50d1ee4cefafaab86b36bd | 617 | Pfam | PF00595 | PDZ domain | 521 | 602 | 1.4E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11321|m.4261 | UnnamedSample_HQ_transcript/11321 | Coverage 0.938 too low. | 64b65740d124b980a0b4fa1a23301966 | 1255 | Pfam | PF01448 | ELM2 domain | 8 | 62 | 2.8E-8 | T | 22-09-2020 | IPR000949 | ELM2 domain |
| UnnamedSample_HQ_transcript/22825|m.7647 | UnnamedSample_HQ_transcript/22825 | Coverage 0.786 too low. | 0f283902d253fddb427c1a330a81d292 | 683 | Pfam | PF00249 | Myb-like DNA-binding domain | 418 | 459 | 1.9E-7 | T | 22-09-2020 | IPR001005 | SANT/Myb domain |
| UnnamedSample_HQ_transcript/18092|m.6328 | UnnamedSample_HQ_transcript/18092 | Coverage 0.128 too low. | c8d45b7a29d841acd8ae9d1df01316bb | 378 | Pfam | PF01403 | Sema domain | 2 | 154 | 1.4E-36 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/18092|m.6328 | UnnamedSample_HQ_transcript/18092 | Coverage 0.128 too low. | c8d45b7a29d841acd8ae9d1df01316bb | 378 | Pfam | PF01437 | Plexin repeat | 176 | 203 | 7.7E-5 | T | 22-09-2020 | IPR002165 | Plexin repeat |
| UnnamedSample_HQ_transcript/74993|m.18839 | UnnamedSample_HQ_transcript/74993 | Coverage 0.957 too low. | e8fe050abd3bdcd141ff2e5872f7b8ba | 442 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 224 | 357 | 2.0E-42 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/74993|m.18839 | UnnamedSample_HQ_transcript/74993 | Coverage 0.957 too low. | e8fe050abd3bdcd141ff2e5872f7b8ba | 442 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 111 | 165 | 6.5E-11 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/74993|m.18839 | UnnamedSample_HQ_transcript/74993 | Coverage 0.957 too low. | e8fe050abd3bdcd141ff2e5872f7b8ba | 442 | Pfam | PF17862 | AAA+ lid domain | 379 | 423 | 3.6E-11 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/103815|m.23087 | UnnamedSample_HQ_transcript/103815 | Coverage 0.985 too low. | f9dd98425733ea5dc79210d84d749d3d | 292 | Pfam | PF07993 | Male sterility protein | 2 | 72 | 7.6E-10 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/103815|m.23087 | UnnamedSample_HQ_transcript/103815 | Coverage 0.985 too low. | f9dd98425733ea5dc79210d84d749d3d | 292 | Pfam | PF03015 | Male sterility protein | 145 | 238 | 9.9E-21 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/72818|m.18444 | UnnamedSample_HQ_transcript/72818 | Coverage 0.802 too low. | 8df64c5b141126e27c0301e0b757c28f | 340 | Pfam | PF00412 | LIM domain | 265 | 318 | 2.0E-8 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/72818|m.18444 | UnnamedSample_HQ_transcript/72818 | Coverage 0.802 too low. | 8df64c5b141126e27c0301e0b757c28f | 340 | Pfam | PF00412 | LIM domain | 206 | 260 | 3.5E-15 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/72818|m.18444 | UnnamedSample_HQ_transcript/72818 | Coverage 0.802 too low. | 8df64c5b141126e27c0301e0b757c28f | 340 | Pfam | PF00412 | LIM domain | 138 | 199 | 3.4E-7 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/72818|m.18444 | UnnamedSample_HQ_transcript/72818 | Coverage 0.802 too low. | 8df64c5b141126e27c0301e0b757c28f | 340 | Pfam | PF00412 | LIM domain | 13 | 67 | 2.0E-15 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/72818|m.18444 | UnnamedSample_HQ_transcript/72818 | Coverage 0.802 too low. | 8df64c5b141126e27c0301e0b757c28f | 340 | Pfam | PF00412 | LIM domain | 74 | 127 | 3.8E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 501 | 552 | 1.9E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 455 | 511 | 1.7E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 361 | 418 | 5.3E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 561 | 613 | 1.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 388 | 443 | 3.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5986|m.2539 | UnnamedSample_HQ_transcript/5986 | Coverage 0.399 too low. | 8ee42802f46698cde089a88b9fea5279 | 1054 | Pfam | PF06482 | Collagenase NC10 and Endostatin | 840 | 1011 | 1.2E-70 | T | 22-09-2020 | IPR010515 | Collagenase NC10/endostatin |
| UnnamedSample_HQ_transcript/112005|m.24079 | UnnamedSample_HQ_transcript/112005 | Identity 0.590 too low. | 8216d04c7e4e62e9c977a7457ca341a2 | 252 | Pfam | PF00501 | AMP-binding enzyme | 107 | 237 | 1.3E-16 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/49397|m.13889 | UnnamedSample_HQ_transcript/49397 | Coverage 0.927 too low. | 0432320404298b45e7abbee1c9db5af5 | 519 | Pfam | PF07690 | Major Facilitator Superfamily | 5 | 290 | 3.1E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/42166|m.12301 | UnnamedSample_HQ_transcript/42166 | Coverage 0.149 too low. | 0432320404298b45e7abbee1c9db5af5 | 519 | Pfam | PF07690 | Major Facilitator Superfamily | 5 | 290 | 3.1E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/36780|m.11111 | UnnamedSample_HQ_transcript/36780 | Coverage 0.150 too low. | 0432320404298b45e7abbee1c9db5af5 | 519 | Pfam | PF07690 | Major Facilitator Superfamily | 5 | 290 | 3.1E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/30144|m.9513 | UnnamedSample_HQ_transcript/30144 | Coverage 0.818 too low. | bd114ae2c53584ce348105a167c83943 | 912 | Pfam | PF00168 | C2 domain | 149 | 234 | 9.5E-18 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/8933|m.3491 | UnnamedSample_HQ_transcript/8933 | Coverage 0.216 too low. | 753a3922c10430bd501757b1737639c7 | 279 | Pfam | PF15997 | Domain of unknown function (DUF4772) | 5 | 120 | 5.4E-34 | T | 22-09-2020 | IPR031940 | Domain of unknown function DUF4772 |
| UnnamedSample_HQ_transcript/89364|m.21139 | UnnamedSample_HQ_transcript/89364 | Coverage 0.728 too low. | cf74ba42c820090b724734f67717e7f8 | 285 | Pfam | PF01151 | GNS1/SUR4 family | 25 | 262 | 7.3E-60 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/81811|m.20002 | UnnamedSample_HQ_transcript/81811 | Coverage 0.764 too low. | cf74ba42c820090b724734f67717e7f8 | 285 | Pfam | PF01151 | GNS1/SUR4 family | 25 | 262 | 7.3E-60 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/93657|m.21759 | UnnamedSample_HQ_transcript/93657 | Coverage 0.946 too low. | b3a7b612b0afaa845317e514751f963a | 228 | Pfam | PF00041 | Fibronectin type III domain | 138 | 199 | 1.4E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/75040|m.18852 | UnnamedSample_HQ_transcript/75040 | Identity 0.480 too low. | b3a7b612b0afaa845317e514751f963a | 228 | Pfam | PF00041 | Fibronectin type III domain | 138 | 199 | 1.4E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/99313|m.22542 | UnnamedSample_HQ_transcript/99313 | Coverage 0.362 too low. | b3a7b612b0afaa845317e514751f963a | 228 | Pfam | PF00041 | Fibronectin type III domain | 138 | 199 | 1.4E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/87557|m.20875 | UnnamedSample_HQ_transcript/87557 | Identity 0.535 too low. | b3a7b612b0afaa845317e514751f963a | 228 | Pfam | PF00041 | Fibronectin type III domain | 138 | 199 | 1.4E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/95668|m.22045 | UnnamedSample_HQ_transcript/95668 | Coverage 0.987 too low. | 9ee5290f1345ec237343f1509d79d7e9 | 346 | Pfam | PF09726 | Macoilin family | 15 | 336 | 1.3E-22 | T | 22-09-2020 | IPR019130 | Macoilin |
| UnnamedSample_HQ_transcript/4863|m.2139 | UnnamedSample_HQ_transcript/4863 | Coverage 0.936 too low. | 390e06b4e50f89e0d08dd6a78c71b423 | 525 | Pfam | PF05380 | Pao retrotransposon peptidase | 259 | 420 | 3.2E-47 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/3868|m.1760 | UnnamedSample_HQ_transcript/3868 | Coverage 0.096 too low. | 9778719f87f0d0e2f832a343e9d1ff0c | 1399 | Pfam | PF07064 | RIC1 | 693 | 942 | 1.6E-84 | T | 22-09-2020 | IPR009771 | Ribosome control protein 1 |
| UnnamedSample_HQ_transcript/6707|m.2776 | UnnamedSample_HQ_transcript/6707 | Coverage 0.806 too low. | 0ff86ea336ba64a7c5266ea06996719e | 908 | Pfam | PF03131 | bZIP Maf transcription factor | 756 | 844 | 1.6E-21 | T | 22-09-2020 | IPR004826 | Basic leucine zipper domain, Maf-type |
| UnnamedSample_HQ_transcript/8826|m.3456 | UnnamedSample_HQ_transcript/8826 | Coverage 0.071 too low. | c08609886bce5bfdbdcc47a86da274b5 | 524 | Pfam | PF02865 | STAT protein, protein interaction domain | 4 | 50 | 3.1E-7 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/8826|m.3456 | UnnamedSample_HQ_transcript/8826 | Coverage 0.071 too low. | c08609886bce5bfdbdcc47a86da274b5 | 524 | Pfam | PF02864 | STAT protein, DNA binding domain | 274 | 406 | 1.1E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/8826|m.3456 | UnnamedSample_HQ_transcript/8826 | Coverage 0.071 too low. | c08609886bce5bfdbdcc47a86da274b5 | 524 | Pfam | PF01017 | STAT protein, all-alpha domain | 73 | 259 | 1.5E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/84166|m.20370 | UnnamedSample_HQ_transcript/84166 | Coverage 0.127 too low. | a88b083b9234d71de32722fbc6703cca | 209 | Pfam | PF00261 | Tropomyosin | 2 | 208 | 5.4E-84 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/21501|m.7281 | UnnamedSample_HQ_transcript/21501 | Coverage 0.841 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/21501|m.7281 | UnnamedSample_HQ_transcript/21501 | Coverage 0.841 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/22540|m.7583 | UnnamedSample_HQ_transcript/22540 | Coverage 0.851 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/22540|m.7583 | UnnamedSample_HQ_transcript/22540 | Coverage 0.851 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/46708|m.13302 | UnnamedSample_HQ_transcript/46708 | Coverage 0.855 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/46708|m.13302 | UnnamedSample_HQ_transcript/46708 | Coverage 0.855 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/18634|m.6480 | UnnamedSample_HQ_transcript/18634 | Coverage 0.817 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/18634|m.6480 | UnnamedSample_HQ_transcript/18634 | Coverage 0.817 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/22249|m.7500 | UnnamedSample_HQ_transcript/22249 | Coverage 0.860 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/22249|m.7500 | UnnamedSample_HQ_transcript/22249 | Coverage 0.860 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/25326|m.8291 | UnnamedSample_HQ_transcript/25326 | Coverage 0.891 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/25326|m.8291 | UnnamedSample_HQ_transcript/25326 | Coverage 0.891 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/25362|m.8305 | UnnamedSample_HQ_transcript/25362 | Coverage 0.888 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/25362|m.8305 | UnnamedSample_HQ_transcript/25362 | Coverage 0.888 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/38537|m.11521 | UnnamedSample_HQ_transcript/38537 | Coverage 0.796 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00069 | Protein kinase domain | 335 | 583 | 1.4E-71 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/38537|m.11521 | UnnamedSample_HQ_transcript/38537 | Coverage 0.796 too low. | 5d3717a75c1ca0c8f03d76608dbe42bc | 604 | Pfam | PF00786 | P21-Rho-binding domain | 11 | 48 | 9.9E-11 | T | 22-09-2020 | IPR000095 | CRIB domain |
| UnnamedSample_HQ_transcript/69370|m.17823 | UnnamedSample_HQ_transcript/69370 | Coverage 0.960 too low. | 8d7471819a0de843addd5ceb91bd18ff | 391 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 107 | 301 | 2.3E-31 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/5672|m.2415 | UnnamedSample_HQ_transcript/5672 | Identity 0.731 too low. | b500579f5a7fe0b940245d9f43d48215 | 1177 | Pfam | PF01753 | MYND finger | 1138 | 1175 | 5.6E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/7627|m.3063 | UnnamedSample_HQ_transcript/7627 | Identity 0.718 too low. | b500579f5a7fe0b940245d9f43d48215 | 1177 | Pfam | PF01753 | MYND finger | 1138 | 1175 | 5.6E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/3967|m.1795 | UnnamedSample_HQ_transcript/3967 | Identity 0.750 too low. | b500579f5a7fe0b940245d9f43d48215 | 1177 | Pfam | PF01753 | MYND finger | 1138 | 1175 | 5.6E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/2466|m.1223 | UnnamedSample_HQ_transcript/2466 | Identity 0.775 too low. | b500579f5a7fe0b940245d9f43d48215 | 1177 | Pfam | PF01753 | MYND finger | 1138 | 1175 | 5.6E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/8259|m.3276 | UnnamedSample_HQ_transcript/8259 | Identity 0.713 too low. | b500579f5a7fe0b940245d9f43d48215 | 1177 | Pfam | PF01753 | MYND finger | 1138 | 1175 | 5.6E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/27093|m.8742 | UnnamedSample_HQ_transcript/27093 | Coverage 0.912 too low. | e1a8b0d8cd018bcf2a82131736952964 | 519 | Pfam | PF08687 | Apx/Shroom domain ASD2 | 222 | 505 | 6.7E-58 | T | 22-09-2020 | IPR014799 | Apx/Shrm Domain 2 |
| UnnamedSample_HQ_transcript/79881|m.19690 | UnnamedSample_HQ_transcript/79881 | Identity 0.936 too low. | 2fc6cb29ae81ed16a1fc8eaed75f550f | 482 | Pfam | PF00083 | Sugar (and other) transporter | 26 | 451 | 2.6E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/22953|m.7677 | UnnamedSample_HQ_transcript/22953 | Coverage 0.132 too low. | 7ffe9c51f0f8cfc3aae7b74b9a87d580 | 522 | Pfam | PF00335 | Tetraspanin family | 69 | 341 | 4.0E-21 | T | 22-09-2020 | IPR018499 | Tetraspanin/Peripherin |
| UnnamedSample_HQ_transcript/15418|m.5526 | UnnamedSample_HQ_transcript/15418 | Coverage 0.115 too low. | 7ffe9c51f0f8cfc3aae7b74b9a87d580 | 522 | Pfam | PF00335 | Tetraspanin family | 69 | 341 | 4.0E-21 | T | 22-09-2020 | IPR018499 | Tetraspanin/Peripherin |
| UnnamedSample_HQ_transcript/34786|m.10669 | UnnamedSample_HQ_transcript/34786 | Identity 0.827 too low. | 3195d3fcf068182055e04b151737a575 | 669 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 57 | 490 | 1.2E-136 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/34786|m.10669 | UnnamedSample_HQ_transcript/34786 | Identity 0.827 too low. | 3195d3fcf068182055e04b151737a575 | 669 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 307 | 420 | 8.1E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/48285|m.13646 | UnnamedSample_HQ_transcript/48285 | Coverage 0.682 too low. | 8e681445a83b55899ed032efa6a9c03b | 463 | Pfam | PF00083 | Sugar (and other) transporter | 29 | 431 | 2.9E-56 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/63580|m.16748 | UnnamedSample_HQ_transcript/63580 | Coverage 0.811 too low. | 8e681445a83b55899ed032efa6a9c03b | 463 | Pfam | PF00083 | Sugar (and other) transporter | 29 | 431 | 2.9E-56 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/54801|m.15005 | UnnamedSample_HQ_transcript/54801 | Coverage 0.728 too low. | 8e681445a83b55899ed032efa6a9c03b | 463 | Pfam | PF00083 | Sugar (and other) transporter | 29 | 431 | 2.9E-56 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/25466|m.8338 | UnnamedSample_HQ_transcript/25466 | Coverage 0.934 too low. | 9213cd445ca1fcd2b1962b4a74c0a377 | 444 | Pfam | PF00651 | BTB/POZ domain | 22 | 117 | 2.0E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/40909|m.12051 | UnnamedSample_HQ_transcript/40909 | Identity 0.833 too low. | b92b5eccae3fe9991e6d8b449efbd005 | 577 | Pfam | PF10516 | SHNi-TPR | 310 | 342 | 6.6E-7 | T | 22-09-2020 | IPR019544 | Tetratricopeptide, SHNi-TPR domain |
| UnnamedSample_HQ_transcript/37472|m.11266 | UnnamedSample_HQ_transcript/37472 | Identity 0.835 too low. | b92b5eccae3fe9991e6d8b449efbd005 | 577 | Pfam | PF10516 | SHNi-TPR | 310 | 342 | 6.6E-7 | T | 22-09-2020 | IPR019544 | Tetratricopeptide, SHNi-TPR domain |
| UnnamedSample_HQ_transcript/45977|m.13135 | UnnamedSample_HQ_transcript/45977 | Identity 0.743 too low. | b92b5eccae3fe9991e6d8b449efbd005 | 577 | Pfam | PF10516 | SHNi-TPR | 310 | 342 | 6.6E-7 | T | 22-09-2020 | IPR019544 | Tetratricopeptide, SHNi-TPR domain |
| UnnamedSample_HQ_transcript/104466|m.23162 | UnnamedSample_HQ_transcript/104466 | Coverage 0.266 too low. | 94113e95614252843bb9bbacbd27fd99 | 297 | Pfam | PF00226 | DnaJ domain | 32 | 97 | 1.9E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/16015|m.5713 | UnnamedSample_HQ_transcript/16015 | Coverage 0.756 too low. | e318bf12091e2b43d561118998cef9d2 | 482 | Pfam | PF00621 | RhoGEF domain | 41 | 222 | 1.9E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/77226|m.19247 | UnnamedSample_HQ_transcript/77226 | Coverage 0.952 too low. | 048828d42ba7d3ada8b5443e8c8cd313 | 411 | Pfam | PF16486 | N-terminal domain of argonaute | 146 | 279 | 5.9E-17 | T | 22-09-2020 | IPR032474 | Protein argonaute, N-terminal |
| UnnamedSample_HQ_transcript/77226|m.19247 | UnnamedSample_HQ_transcript/77226 | Coverage 0.952 too low. | 048828d42ba7d3ada8b5443e8c8cd313 | 411 | Pfam | PF08699 | Argonaute linker 1 domain | 292 | 338 | 1.6E-11 | T | 22-09-2020 | IPR014811 | Argonaute, linker 1 domain |
| UnnamedSample_HQ_transcript/2953|m.1428 | UnnamedSample_HQ_transcript/2953 | Coverage 0.139 too low. | cc42ac8581d422527a939e2b21b0ab30 | 580 | Pfam | PF07534 | TLD | 426 | 577 | 1.4E-32 | T | 22-09-2020 | IPR006571 | TLDc domain |
| UnnamedSample_HQ_transcript/2953|m.1428 | UnnamedSample_HQ_transcript/2953 | Coverage 0.139 too low. | cc42ac8581d422527a939e2b21b0ab30 | 580 | Pfam | PF00566 | Rab-GTPase-TBC domain | 76 | 280 | 3.6E-15 | T | 22-09-2020 | IPR000195 | Rab-GTPase-TBC domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
